IL118103A - Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal - Google Patents

Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal

Info

Publication number
IL118103A
IL118103A IL11810396A IL11810396A IL118103A IL 118103 A IL118103 A IL 118103A IL 11810396 A IL11810396 A IL 11810396A IL 11810396 A IL11810396 A IL 11810396A IL 118103 A IL118103 A IL 118103A
Authority
IL
Israel
Prior art keywords
macroglobulins
alpha1
alpha2
lysine
factor
Prior art date
Application number
IL11810396A
Other languages
English (en)
Other versions
IL118103A0 (en
Original Assignee
Tomson U S A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomson U S A Ltd filed Critical Tomson U S A Ltd
Publication of IL118103A0 publication Critical patent/IL118103A0/xx
Publication of IL118103A publication Critical patent/IL118103A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11810396A 1995-05-01 1996-05-01 Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal IL118103A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43188395A 1995-05-01 1995-05-01
US48554895A 1995-06-07 1995-06-07
US64193696A 1996-05-01 1996-05-01

Publications (2)

Publication Number Publication Date
IL118103A0 IL118103A0 (en) 1997-03-18
IL118103A true IL118103A (en) 2000-02-29

Family

ID=27411755

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11810396A IL118103A (en) 1995-05-01 1996-05-01 Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal

Country Status (10)

Country Link
EP (2) EP0826003B1 (de)
CN (1) CN1221568C (de)
AT (1) ATE205221T1 (de)
BG (1) BG64056B1 (de)
CA (1) CA2220347C (de)
DE (1) DE69615015T2 (de)
DK (1) DK0826003T3 (de)
EA (1) EA001100B1 (de)
ES (1) ES2163028T3 (de)
IL (1) IL118103A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008057479A1 (de) 2008-11-14 2010-05-20 Bernhard, Stefan, Dr. Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse
CN116466071A (zh) * 2020-12-28 2023-07-21 重庆生命知源科技有限公司 上样缓冲液的应用及一种微量蛋白免疫印迹检测方法
CN119746205B (zh) * 2024-12-25 2025-09-30 深圳市浩然盈科通讯科技有限公司 一种智能输液控制方法、系统、存储介质及程序产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
AU2800389A (en) * 1987-12-02 1989-07-05 Regents Of The University Of California, The Aids-related anti-t-cell antibody test
GB9209874D0 (en) * 1992-05-07 1992-06-24 Ml Lab Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0826003B1 (de) 2001-09-05
EP0826003A1 (de) 1998-03-04
DK0826003T3 (da) 2001-11-26
BG64056B1 (bg) 2003-11-28
HK1009457A1 (en) 1999-06-04
CA2220347C (en) 2003-03-18
BG102083A (en) 1998-10-30
EA199700353A1 (ru) 1998-04-30
CA2220347A1 (en) 1996-11-07
DE69615015T2 (de) 2002-06-27
ATE205221T1 (de) 2001-09-15
EP1104770A2 (de) 2001-06-06
CN1221568C (zh) 2005-10-05
ES2163028T3 (es) 2002-01-16
DE69615015D1 (de) 2001-10-11
EA001100B1 (ru) 2000-10-30
CN1189839A (zh) 1998-08-05
EP1104770A3 (de) 2001-06-27
IL118103A0 (en) 1997-03-18

Similar Documents

Publication Publication Date Title
EA200000596A1 (ru) Tat вич-1 или его производные для профилактической и лечебной вакцинации
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
NO20025153L (no) Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV
WO2002068654A3 (es) Poxvirus recombinantes para proteinas quimericas del virus de la inmunodeficiencia humana
WO2002014362A3 (en) A hepatitis c virus non-structural ns3/4a fusion gene
IL115074A0 (en) A novel salt of (1s,4r)-cis-4--Ú2-amino-6-(cyclopropylamino)-9h-purin-9-yl-¾- 2-cyclopentene-1-methanol solvates thereof their preparation and pharmaceutical compositions containing them
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
WO2005052159A8 (en) Latent phase viral interleukin-10-(vii-10) and uses thereof
EP0719281B1 (de) Vielfältig verzweigte peptidkonstruktion zur bekämpfung von hiv
US5622933A (en) Multiple branch peptide constructions for use against HIV
IL118103A0 (en) Compositions and methods for detecting and treating acquired immunodeficiency syndrome
DK0671946T3 (da) Immunreaktive peptider fra Epstein-Barr-virus
BG101175A (bg) Тройна анти-нiv комбинация
BR9608837A (pt) "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano"
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
AP9901615A0 (en) Multiple branch peptide constructions.
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
CA2171531C (en) Multiple branch peptide constructions for use against hiv
WO1991018618A3 (en) Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
WO2002026253A1 (en) A vaccine for acids and its preparation and use
EP0323424A3 (de) Peptide, übereinstimmend mit HIV-env 583-599, deren Analoge und Verwendung dieser Peptide
PT1366080E (pt) Anticorpo natural activo contra o vírus hiv
JP3725899B6 (ja) Ｈｉｖに対して使用するための多分岐ペプチド構築物
US20060155108A1 (en) Multiple branch peptide construction

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees